CTRI/2021/01/030549
Completed
Phase 3
A COMPARATIVE CLINICAL STUDY TO ASSESS THE EFFICACY OF BHALLATAKA VISHADI AGADA LEPA AND ARKA TAILA LEPA IN THE MANAGEMENT OF VICHARCHIKA W.S.R. ECZEMA
DR L K PATTAR0 sites130 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Sponsor
- DR L K PATTAR
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed as Vicharchika on the basis of Lakshanas like Kandu, Pidaka, Shyavavarna, with or without srava and Rukshata.
- •Patients who are willing to participate for the study
Exclusion Criteria
- •Patients on steroid therapy.
- •Lesions with secondary infections.
- •Patients who are unfit for Lepana Karma.
- •Patients suffering from systemic disorders which interferes with the course of treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To study Viddha-agnikarma therapy with therapeutic ultrasound for relieving heel paiHealth Condition 1: M796- Pain in limb, hand, foot, fingersand toesCTRI/2023/03/050261DR KHUSHDEEP KAUR
Not yet recruiting
Not Applicable
EFFICACY OF VISHNU TAILA NASYA AND EKANGAVEERA RAS IN ARDITAVATA W.S.R TO BELLS PALSY.CTRI/2019/09/021461Dr Sangameshwar N Doddagoudar
Recruiting
Phase 1
A study to reveal better drug of choice between Yashtimadhu Ghrita and Yashtimadhu Ghrita for treatment of Anal-FisureCTRI/2020/01/022856Dr Bhardwaj Bhosekar
Not yet recruiting
Not Applicable
Comparing the effect of two drugs (AMRITABHALLATAKA and AROGYAVARDHINI VATI) After therapeutic purgation in PsoriasisHealth Condition 1: L409- Psoriasis, unspecifiedHealth Condition 2: L409- Psoriasis, unspecifiedCTRI/2022/02/039985All India Institute Of Ayurveda
Not yet recruiting
Phase 1
Management of Asthikshaya with special reference to Osteoporosis by Panchatikta Ksheera Basti (Medicated Enema) and Shamanoushadhi (Internal Medication)Health Condition 1: null- Having Osteoporotic conditionHealth Condition 2: J454- Moderate persistent asthmaCTRI/2018/08/015295Rajiv Gandhi University of Health Sciences Karnataka Bangalore